Mitapivat (Pyrukynd)
Revision as of 17:34, 6 January 2022 by Warner-admin (talk | contribs) (Created page with "==Mechanism of action== Pyruvate kinase activator ==Preliminary data== ===Pyruvate kinase deficiency=== #'''AG348-C-003:''' Grace RF, Rose C, Layton DM, Galactéros F, Barcel...")
Mechanism of action
Pyruvate kinase activator
Preliminary data
Pyruvate kinase deficiency
- AG348-C-003: Grace RF, Rose C, Layton DM, Galactéros F, Barcellini W, Morton DH, van Beers EJ, Yaish H, Ravindranath Y, Kuo KHM, Sheth S, Kwiatkowski JL, Barbier AJ, Bodie S, Silver B, Hua L, Kung C, Hawkins P, Jouvin MH, Bowden C, Glader B. Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency. N Engl J Med. 2019 Sep 5;381(10):933-944. link to original article PubMed NCT02476916